Date: 2012-09-12
Type of information: Production agreement
Compound:
Company: CMC Biologics (Denmark - USA) Innomedica (Finland)
Therapeutic area:
Type agreement: services
production
manufacturing
collaboration
Action mechanism:
Disease:
Details: CMC Biologics, a leading contract manufacturing organization, and Innomedica, a life sciences business development company specialized in Japan market, have entered into an agreement to facilitate CMC Biologics\' customer base in the Japan market.
Financial terms:
Latest news:
